Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT (Mar, 10.1007/s12325-024-02810-3, 2024)
ADVANCES IN THERAPY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ADVANCES IN THERAPY(2024)